Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV) — Stella

Home/Human Papillomavirus/

View on ClinicalTrials.gov

Recruiting

Back to Human Papillomavirus trials

Trial locations(1 site)

United States

MD Anderson Cancer Center, Houston, Texas

Key details

Sponsor

M.D. Anderson Cancer Center

Enrollment target

~600 participants

Started

July 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

21 Years and older

Sex

Female only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.